[Assessment and truth -- how many cardio- and cerebrovascular events are in fact to be led back to taking rofecoxib]

Med Klin (Munich). 2006 Aug 15;101(8):673-5; author reply 678-9.
[Article in German]
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cardiovascular Diseases / chemically induced*
  • Cerebrovascular Disorders / chemically induced*
  • Confidence Intervals
  • Controlled Clinical Trials as Topic
  • Cyclooxygenase 2 Inhibitors / administration & dosage
  • Cyclooxygenase 2 Inhibitors / adverse effects*
  • Databases as Topic
  • Humans
  • Lactones / administration & dosage
  • Lactones / adverse effects*
  • Myocardial Infarction / chemically induced
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Sulfones / administration & dosage
  • Sulfones / adverse effects*
  • Time Factors

Substances

  • Cyclooxygenase 2 Inhibitors
  • Lactones
  • Sulfones
  • rofecoxib